Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05195905 · ClinicalTrials.gov registry record · NA
PMEG for Repair of Pararenal and Thoracoabdominal Aortic Aneurysm
A NA study of Thoracoabdominal Aortic Aneurysm and Pararenal Aortic Aneurysm, sponsored by Konstantinos Dean Arnaoutakis, MD.
- Recruiting
- Registry status
- NA
- Development phase
- 30
- Enrollment target
- 2
- Study locations
NCT05195905: Recruiting NA study of Thoracoabdominal Aortic Aneurysm and Pararenal Aortic Aneurysm, sponsored by Konstantinos Dean Arnaoutakis, MD.
NCT05195905 is a NA study of Thoracoabdominal Aortic Aneurysm and Pararenal Aortic Aneurysm that is actively recruiting participants, run by Konstantinos Dean Arnaoutakis, MD. The registered enrollment target is 30 participants, below the 197-participant average among 11 other Thoracoabdominal Aortic Aneurysm trials with a reported enrollment target (85% lower). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05195905, a NA study of Thoracoabdominal Aortic Aneurysm and Pararenal Aortic Aneurysm, is actively recruiting participants, sponsored by Konstantinos Dean Arnaoutakis, MD.
- RECRUITING
- Registry status
- NA
- Development phase
- 30 participants
- Enrollment target
- 2
- Study locations
Study Summary
The primary objective is to evaluate the safety and effectiveness of surgeon modified endografts for the treatment of pararenal and thoracoabdominal aortic pathology in patients who are not candidate for traditional open repair due to comorbid issues and their anatomy is not amenable to commercially available endografts.
Primary Outcome
Major adverse events include: aortic-related mortality, major stroke, myocardial Infarction, permanent spinal cord ischemia, renal failure, bowel Ischemia (requiring laparotomy/bowel resection), respiratory failure (mechanical ventilation \>72 hours or requiring tracheostomy), lower extremity ischemia, blood loss ≥1,000cc
Conditions Studied
Interventions
- DEVICE PMEG
Study Locations (2)
Florida
- Tampa General Hospital - Tampa
- University of South Florida - South Tampa Campus - Tampa
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2023-06-06 |
| Est. Completion | 2029-08 |
| Phase | NA |
What NCT05195905 shows while recruiting
NCT05195905 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 30 participants, a relatively small participant target, below the 197-participant average among 11 other Thoracoabdominal Aortic Aneurysm trials with a reported enrollment target (85% lower).
The record links to 2 conditions, with Thoracoabdominal Aortic Aneurysm appearing as the primary indexed condition, and to 1 intervention - of which PMEG is the first listed.
NCT05195905 reports a single indexed study location in Florida.
Frequently Asked Questions
What is clinical trial NCT05195905 about?
NCT05195905 is a clinical study titled "PMEG for Repair of Pararenal and Thoracoabdominal Aortic Aneurysm". The primary objective is to evaluate the safety and effectiveness of surgeon modified endografts for the treatment of pararenal and thoracoabdominal aortic pathology in patients who are not candidate for traditional open repair due to comorbid issues and their anatomy is not amenable to commercially...
What is the current status of trial NCT05195905?
This trial is currently recruiting. It is a NA study. The enrollment target is 30 participants. The study started on 2023-06-06. Estimated completion is 2029-08.
What conditions does trial NCT05195905 study?
This clinical trial studies the following conditions: Thoracoabdominal Aortic Aneurysm, Pararenal Aortic Aneurysm.
What interventions are being tested in trial NCT05195905?
The interventions under investigation include: PMEG (DEVICE).
Who is sponsoring clinical trial NCT05195905?
This trial is sponsored by Konstantinos Dean Arnaoutakis, MD, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05195905 being conducted?
This trial has 2 study locations across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Thoracoabdominal Aortic Aneurysm
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05195905's enrollment target sits among peer trials
30 10th of 11 higher than 1 of 11 other Thoracoabdominal Aortic Aneurysm trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Thoracoabdominal Aortic Aneurysm trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Evaluation of Branch Endografts in the Treatment of Aortic Aneurysms
RECRUITING · NA
-
CAAAs, TAAAs, Aortic Arch Aneurysms or Dissections With Fenestrated/Branched Stent Graft
RECRUITING · NA
-
Evaluation of the Cook Custom Aortic Endograft, the Zenith t-Branch Endovascular Graft, and Surgeon-Modified Endograft in Treating Aortic Pathologies
RECRUITING · NA
-
Clinical Outcomes and Major Adverse Events in Patients Treated With Physician-Modified Fenestrated and Branched Stent Grafts
RECRUITING · NA
-
Endovascular Exclusion of Thoracoabdominal and/or Paravisceral Abdominal Aortic Aneurysm
RECRUITING · NA
-
Physician Modified Endograft For Complex Aortic Aneurysm Repair
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00977977 · 30 participants · Phase 2
Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy
- NCT01459107 · 30 participants · Phase 2
Human Upper Extremity Allotransplantation
- NCT01666080 · 30 participants · NA
Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)
- NCT01720836 · 30 participants · Phase 1
Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI